NCT00496574

Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma

Evaluation of Long-term Clinical Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Medical University of Lodz · Academic / Other
• Sex: All
• Age: 8 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to assess the effect of specific immunotherapy (SIT) to dust mites on clinical symptoms, reliever drugs usage, inhaled glucocorticosteroid usage, quality of life, lung function, bronchial hyperreactivity with methacholine, and presence and type of allergy after three years of SIT in children with asthma.

Detailed description

According to Global Initiative for Asthma treatment of asthma is based on avoidance of allergens, pharmacological treatment, and specific immunotherapy. The aim of the study is to assess the effect of specific immunotherapy (SIT) to dust mites on clinical symptoms, reliever drugs usage, inhaled glucocorticosteroid usage, quality of life, lung function, bronchial hyperreactivity with methacholine, and presence and type of allergy after three years of SIT in children with asthma.

Conditions

• Asthma

Interventions

Type	Name	Description
BIOLOGICAL	Novo Helisen Depot, Phostal	subcutaneous immunotherapy

Timeline

• Start date: 2006-05-01
• Primary completion: 2013-11-01
• Completion: 2013-12-01
• First posted: 2007-07-04
• Last updated: 2013-02-07

Locations

1 site across 1 country: Poland